Evidence map›Paper›PMID 34706056›Full record

ArticleCancer2022

The impact of the COVID-19 pandemic on African American cancer survivors.

Jennifer L Beebe-Dimmer, Christine M Lusk, Julie J Ruterbusch, Tara E Baird, Stephanie S Pandolfi, Angela S Wenzlaff, Theresa A Hastert, Felicity W K Harper, Hayley S Thompson, Ann G Schwartz

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Disruption in Cancer Care During Early Survivorship due to the COVID-19 Pandemic and Patient Satisfaction with Telemedicine.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jennifer L Beebe-DimmerPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.ORCID 0000-0002-4320-739X
Christine M LuskPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Julie J RuterbuschPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Tara E BairdPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Stephanie S PandolfiPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Angela S WenzlaffPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Theresa A HastertPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.ORCID 0000-0001-6251-6422
Felicity W K HarperPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Hayley S ThompsonPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Ann G SchwartzPopulation Studies and Disparities Research Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer · 1985 to 2026
$68.4M
The impact of the COVID-19 pandemic on African American cancer survivors and their caregiversU01CA199240 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer, Ann G. Schwartz · 2017 to 2026
$15.2M
NCI NIH HHS P30 CA022453NCI NIH HHS U01 CA199240
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has had profound effects on population health to date. African American cancer survivors are particularly vulnerable to developing severe consequences; therefore, understanding the impact of the virus on this patient population is critical.

methodsThe Detroit Research on Cancer Survivors cohort is a unique effort to understand the determinants of poor outcomes in African American cancer survivors. To date, more than 4500 cancer survivors and nearly 950 primary caregivers have been enrolled; participation includes a survey and the collection of biospecimens, medical records, and tumor tissue. Beginning in the spring of 2020, a supplemental survey focusing on the impact of COVID-19 was offered to enrolled participants. The analysis included 890 survivors.

resultsNearly all survivors (>99%) reported changes in their daily activities in an effort to reduce the risk of infection. More than 40% of the survivors reported some disruption in their access to medical care. A substantial proportion of the survivors (>40%) reported feeling anxious, depressed, and/or isolated during the COVID-19 pandemic. Approximately 40% of the patients reported changes in health behaviors shown to negatively affect survivorship outcomes (physical inactivity, smoking, and alcohol use) as a result of the pandemic.

conclusionsThe influence of the COVID-19 pandemic on African American cancer survivors is substantial: it has affected both their physical and mental health. Coupled with changes in health behaviors, these factors will likely affect outcomes in this high-risk patient population, and this makes further study and interventions necessary to mitigate the long-term impact of the pandemic on cancer outcomes.

Indexed as

Cancer SurvivorsCOVID-19NeoplasmsBlack or African AmericanHumansPandemicsSARS-CoV-2African Americancoronavirusepidemiologyoutcomesquality of life

Identifiers

PMID34706056
PMCPMC8652865
OpenAlexW3209394542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.